PATHFINDER: ipatasertib with non-taxane chemotherapy in patients with aTNBC

(1:20)

Dr. Dent Discusses Ipatasertib in Triple-Negative Breast Cancer

(2:22)

Phase I study of ipatasertib with chemotherapy and atezolizumab

(2:21)

Introduction to Rx Pathfinder

(5:16)

MedAI #50: AI for Clinical Trials and Precision Medicine | Ruishan Liu

(56:16)

Final results of PAKT: capivasertib and paclitaxel for TNBC

(3:35)

Message | Easter 2023 @pathfinderstl

(40:56)

MedAI #54: FlashAttention: Fast and Memory-Efficient Exact Attention with IO-Awareness | Tri Dao

(47:47)

Building AI models for healthcare (ML Tech Talks)

(48:3)

Targeting the PI3K-Akt-mTOR Pathway

(7:24)

Intelligent Clinical trials: How AI can improve patient engagement and Clinical trial outcomes #ai

(14:32)

Easter 2023 @pathfinderstl

(1:21:35)

MedAI #51: Datamodels - Predicting Predictions from Training Data | Andrew Ilyas

(56:56)

AKT Signaling Pathway | Regulation and Downstream Effects

(8:50)

pathfinder song

(2:31)

Revolutionizing Clinical Trials: The Power of AI Transforming Healthcare

(5:24)

The PI3K Signaling Pathway

(1:50)

Gemcitabine/nab-paclitaxel compared with 5-fluorouracil/leucovorin/liposomal irinotecan show sim...

(11:46)

Robotic Hysterectomy with ICG sentinel lymph node maping

(36:51)

Acts Redux - Catalyst Three: Human Suffering (Week 3) | Message

(44:34)

Understanding Bacteremia: Risks and Realities You Need to Know

(21)

Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis

(1:53)

Leprosy - Neuropathic Tarsal Disorganization

(10:21)

Nivolumab and ipilimumab shows a significantly higher OS rate in nccRCC compared to standard of ...

(4:27)

Finding Your Flow: How to Thrive (Not Just Survive) as an SLP

(7:29)

Crystal Deposition Disorders - Basic Calcium Phosphate Crystal Deposition Disease

(8:51)

Spondyloarthropathies - Reiter's Syndrome And Reactive Arthritis

(8:44)

Current opinion on acute rhinosinusitis

(34:34)

Pembrolizumab shows improvement in overall survival for clear cell renal cell carcinoma

(3:58)